Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Cannara Biotech Inc.

Capitalization 183M 133M 116M 105M 100M 12.3B 190M 1.25B 497M 5.88B 499M 489M 21.23B P/E ratio 2026 *
12.9x
P/E ratio 2027 * 9.1x
Enterprise value 171M 125M 109M 98.42M 94.15M 11.53B 178M 1.18B 466M 5.51B 468M 458M 19.89B EV / Sales 2026 *
1.34x
EV / Sales 2027 * 1.07x
Free-Float
50.23%
Yield 2026 *
-
Yield 2027 * -
1 day-2.16%
1 week-3.21%
Current month-4.23%
1 month+0.56%
3 months+0.56%
6 months+7.10%
Current year+4.02%
1 week 1.79
Extreme 1.79
1.88
1 month 1.74
Extreme 1.74
1.91
Current year 1.67
Extreme 1.67
2.07
1 year 1.06
Extreme 1.06
2.07
3 years 0.52
Extreme 0.52
2.07
5 years 0.52
Extreme 0.52
2.07
10 years 0.5
Extreme 0.5
3.45
Manager TitleAgeSince
Chief Executive Officer 50 30/12/2018
Director of Finance/CFO - 07/11/2020
Chief Tech/Sci/R&D Officer - 31/03/2021
Director TitleAgeSince
Chairman 50 -
Director/Board Member 59 30/12/2018
Director/Board Member - 24/05/2020
Change 5d. change 1-year change 3-years change Capi.($)
-2.16%-3.21%+31.16%+115.48% 134M
0.00%-2.99%+36.36%-46.43% 195M
+1.02%-10.00%+54.69%-58.75% 99.11M
+4.70%-7.25%+78.18%-18.33% 93.46M
Average +0.89%-0.21%+50.10%-2.01% 130.47M
Weighted average by Cap. +0.48%-0.50%+45.99%-2.12%

Financials

2026 *2027 *
Net sales 128M 93.08M 81.36M 73.5M 70.32M 8.61B 133M 878M 348M 4.11B 349M 342M 14.86B 142M 103M 90.36M 81.63M 78.09M 9.56B 148M 975M 386M 4.57B 388M 380M 16.5B
Net income 14.22M 10.35M 9.05M 8.17M 7.82M 957M 14.78M 97.64M 38.7M 457M 38.84M 38.02M 1.65B 20.68M 15.05M 13.16M 11.89M 11.37M 1.39B 21.5M 142M 56.27M 665M 56.48M 55.29M 2.4B
Net Debt -11.5M -8.37M -7.32M -6.61M -6.33M -774M -11.96M -78.99M -31.3M -370M -31.42M -30.76M -1.34B -31.01M -22.57M -19.73M -17.82M -17.05M -2.09B -32.24M -213M -84.38M -997M -84.7M -82.91M -3.6B
Logo Cannara Biotech Inc.
Cannara Biotech Inc. is a Canada-based vertically integrated producer of premium-grade cannabis and cannabis-derivative products for the Quebec and Canadian markets. The Company operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. It owns two mega cultivation facilities based in Quebec spanning over 1,650,000 square feet, providing the Company with 100,000 kilograms of annualized cultivation output. It operates in two segments: Cannabis operations and Real estate operations. The Cannabis operations encompass the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market. The Real estate operations is related to the Farnham and Valleyfield building. The Company's brand portfolio includes Tribal, Nugz, and Orchid CBD. Tribal delivers grade cannabis products. Orchid CBD is a wellness brand that provides CBD-rich cannabis.
Employees
452
Date Price Change Volume
13/03/26 1.810 $ -2.16% 29,159
12/03/26 1.850 $ +1.09% 7,078
11/03/26 1.830 $ -0.54% 8,432
10/03/26 1.840 $ 0.00% 50,060
09/03/26 1.840 $ -1.60% 9,065
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.850CAD
Average target price
3.250CAD
Spread / Average Target
+75.68%

Quarterly revenue - Rate of surprise

SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW